Weixinkang Pharmaceutical Co., LTD
- Biotech or pharma, therapeutic R&D
Weixinkang Pharmaceutical was established in 2002, officially founded in 2006, Xizang Weixinkang Pharmaceutical Co.,Ltd. listed on the mainboard of the Shanghai Stock Exchange (stock code 603676.SH) in 2017, with 13 subsidiaries and nearly 800 employees, distributed in Beijing, Xizang, Inner Mongolia, Hainan, Jiangsu, Hong Kong Singapore and other places.
Guided by clinical needs, the company focuses on the R&D and innovation of generic and innovative drugs. Weixinkang is a comprehensive high-tech medical enterprise integrating medicine R&D, production, and sales, with significant advantages in intravenous vitamins, intravenous trace elements, and intravenous electrolytes,etc.